United States · FDA National Drug Code directory
Emtricitabine and tenofovir disoproxil fumarate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1622_8fb1b15c-e324-4410-9a1b-2b3a2ffee3f6
- Product NDC
- 70771-1622
- Form
- TABLET, FILM COATED
- Composition / generic term
- Emtricitabine and tenofovir disoproxil fumarate
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210701
- Source listing expiry
- 20261231
Source-listed ingredients
- EMTRICITABINE — 167 mg/1
- TENOFOVIR DISOPROXIL FUMARATE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (70771-1622-3) · 70771-1622-3
- 10 BLISTER PACK in 1 CARTON (70771-1622-4) / 10 TABLET, FILM COATED in 1 BLISTER PACK (70771-1622-2) · 70771-1622-4
- 90 TABLET, FILM COATED in 1 BOTTLE (70771-1622-9) · 70771-1622-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →